19
6
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13865 |
Resorcinolnaphthalein
|
RAAS | Endocrinology/Hormones |
Resorcinolnaphthalein 是一种特异性的血管紧张素转换酶 2 激活剂,EC50=19.5 μM。Resorcinolnaphthalein 能够用于高血压和肾纤维化的研究 | |||
T12883 |
Fezagepras
PBI-4050,3-戊基苯乙酸,Setogepram |
GPR | Endocrinology/Hormones; GPCR/G Protein |
Fezagepras (Setogepram) 是一种可口服的 GPR40激动剂和GPR84拮抗剂或反向激动剂。它减轻肾、肝和胰腺纤维化,具有抗纤维化、抗炎和抗增殖作用。 | |||
T4583 |
PFI-2 hydrochloride
(R)-PFI-2 hydrochloride,PFI-2 HCl |
Histone Methyltransferase | Chromatin/Epigenetic |
PFI-2 hydrochloride ((R)-PFI-2 hydrochloride) 是一种有效的、高度选择性的、具有细胞活性的 SETD7 甲基转移酶抑制剂,IC50值为2nM,活性是 (S)-PFI-2 的 500 倍。 | |||
T16708 |
R-268712
|
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
R-268712 是选择性的 ALK5 抑制剂(IC50:2.5 nM)。 | |||
T1987 |
PFI-2
PFI2,PFI 2,(R)-PFI-2 |
Histone Methyltransferase | Chromatin/Epigenetic |
PFI-2 是一种有效、特异性和细胞活性的赖氨酸甲基转移酶 SETD7 抑制剂,Ki 和 IC50值分别为 0.33 和 2 nM。 | |||
T14076 |
A 839977
A839977,A-839977 |
P2X Receptor; Calcium Channel | Membrane transporter/Ion channel; Metabolism; Neuroscience |
A 839977是一种选择性 P2X7 受体拮抗剂,具有抗炎和镇痛活性, 可抑制 P2X7 受体的 BzATP 诱发的钙内流,可用于研究肾纤维化 . | |||
T9953 |
BT173
|
Others | Others |
BT173 是一种新型的同源域相互作用蛋白激酶 2 (HIPK2) 抑制剂,通过抑制 TGF-β1/Smad3 通路减轻肾纤维化。 | |||
T24270 |
KS370G
KS-370-G,KS 370 G,Caffeic Acid Phenethyl Amide |
Others | Others |
KS370G (Caffeic Acid Phenethyl Amide) 抑制 UUO 诱导的肾纤维化标志物表达。KS370G 是一种具有口服活性的降糖和心血管保护剂,可减少梗阻肾脏中胶原蛋白的沉积,并显著降低肾脏炎症趋化因子/粘附分子和单核细胞标志物的表达,改善压力过载小鼠心脏左室肥厚和功能。KS370G 可用于研究肾阻塞性肾病。 | |||
T16886 |
Sinefungin
Adenosyl-Ornithine,西奈芬净,A-9145,Antibiotic 32232RP |
Others; Histone Methyltransferase; Antibiotic; Antifungal | Chromatin/Epigenetic; Microbiology/Virology; Others |
Sinefungin (Adenosyl-Ornithine) 是病毒粒子mRNA (鸟嘌呤-7-)-甲基转移酶、 mRNA (核苷-2'-)-甲基转移酶和病毒增殖的有效抑制剂。它还抑制SET7/9,通过抑制H3K4甲基化来改善肾纤维化。 | |||
T15300 |
Fluorofenidone
AKF-PD |
Others | Others |
Fluorofenidone (AKF-PD) 是 AMR69 的类似物,抗纤维化活性与 AMR69相同,但 Fluorofenidone 的毒性更低,半衰期长。它部分通过 PI3K/Akt 信号通路抑制 NADPH 氧化酶和细胞外基质 (ECM) 的沉积,能够减少肾间质纤维化的发生。 | |||
T79516 |
BT424
|
Src | Angiogenesis; Tyrosine Kinase/Adaptors |
BT424是一种特异性HCK抑制剂,能够调节体外巨噬细胞的活化及自噬,并在UUO模型中改善炎症和肾纤维化。 | |||
T80072 |
Des-Arg9-[Leu8]-Bradykinin acetate
|
Bradykinin Receptor | GPCR/G Protein |
Des-Arg9-[Leu8]-Bradykinin acetate 是一种B1R(缓激肽受体1)拮抗剂,主要应用于肾纤维化的研究。 | |||
T70932 |
L6H9
|
Others | Others |
L6H9 is a novel inhibitor of myeloid differentiation factor 2 (MD2), suppressing HG-induced expression of ACE and AT1 receptor and Angiotensin II (AngII) production in renal NRK‐52E cells, resulting in the decrease in fibrosis markers such as TGF-β and collagen IV. | |||
T73088 |
Mavodelpar
HPP593,REN001,REN001 ; HPP593 |
Others | Others |
Mavodelpar (REN001) 是一种选择性的 PPARδ激动剂。Mavodelpar 抑制肾小球损伤和肾纤维化。Mavodelpar 可用于原发性线粒体肌病 (PMM) 和长链脂肪酸氧化障碍 (LC-FAOD) 的研究。 | |||
T62909 |
SGC agonist 2
|
Others | Others |
SGC agonist 2 是一种有效的可溶性鸟苷酸环化酶 (SGC) 激动剂。其中可溶性鸟苷酸环化酶是 NO-sGC-cGMP 信号通路中的关键信号转导酶。SGC agonist 2 具有潜力进行心血管疾病 (心力衰竭、心绞痛、肺动脉高压、心肌梗塞) 和纤维化疾病 (肾纤维化、系统性硬化症) 的研究。 | |||
T61949 |
Evogliptin
|
Others | Others |
Evogliptin (DA-1229) 是具有口服活性的DPP4抑制剂。Evogliptin 在小鼠模型中具有显著而持久的降糖效果。Evogliptin 通过诱导自噬抑制肝细胞的纤维化和炎症信号的产生。Evogliptin 可用于 2 型糖尿病、慢性肝脏炎症,骨质疏松症及肾功能损害的研究。 | |||
T83770 |
Klotho-derived Peptide 1 (56-87) (human) TFA
KP1 (56-87) |
||
Klotho衍生肽1(KP1)(56-87)是从人类Klotho蛋白质中衍生的肽,具有扰乱TGF-β信号传导的作用。它与TGF-β受体类型1(TGFBR2)和TGF-β受体类型2(TGFBR2;Kds分别为1.41和14.6µM)结合。KP1(10 µg/ml)的预孵育抑制TGF-β在NRK-49F大鼠成纤维细胞中诱导的纤维连接蛋白和α-平滑肌肌动蛋白(α-SMA)水平的增加。在体内,KP1(每天1 mg/kg)选择性地定位于受损的肾脏,并减少血清肌酐和血尿素氮水平,这些是肾功能的标志物,同时也减少了小鼠单侧输尿管阻塞(UUO)和单侧缺血-再灌注损伤诱导的肾脏纤维化模型中的肾纤维化。 | |||
T74142 |
Angiotensin II human TFA
|
||
Angiotensin II human (Angiotensin II) TFA 作为肾素/血管紧张素系统中关键的生物活性肽,扮演着血管收缩剂的角色并在调节人体血压中发挥中心作用。其主要通过与 G 蛋白偶联受体 (GPCRs)、血管紧张素 II 1型受体 (AT1R) 和血管紧张素 II 2型受体 (AT2R) 的相互作用来介导效应,包括刺激交感神经系统、增加醛固酮的生物合成和肾脏功能。此外,Angiotensin II human TFA 促进血管平滑肌细胞的生长和 I 型及 III 型胶原在成纤维细胞中的合成,导致血管壁与心肌增厚及纤维化,并诱导细胞凋亡。还通过LOX-1依赖的氧化还原敏感路径诱导内皮细胞中的毛细血管形成。 | |||
T36673 |
CC 401 dihydrochloride
|
Others | Others |
High affinity JNK inhibitor (Ki values are 25-50 nM). Inhibits JNK via competitive binding of the ATP-binding site of active, phosphorylated JNK. Exhibits > 40-fold selectivity for JNK over p38, ERK, IKK2, protein kinase C, Lck and ZAP70. Hepatoprotective. Also inhibits HCMV replication. Uehara et al (2004) c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation. 78 324 PMID:15316358 |Uehara et al (2005) JNK mediates hepatic ischemia reperfusion injury. J... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3033 |
Deoxycorticosterone acetate
醋酸去氧皮质酮,DOC acetate,Cortexone acetate,11-Deoxycorticosterone acetate,醋酸脱氧皮质酮 |
Glucocorticoid Receptor; Endogenous Metabolite; Adrenergic Receptor | Endocrinology/Hormones; GPCR/G Protein; Metabolism; Neuroscience |
Deoxycorticosterone acetate (Cortexone acetate) 是肾上腺产生的类固醇激素,具有盐皮质激素活性,并作为醛固酮的前体。 | |||
T3S1227 |
Aristolactam I
Aristolactam,Aristololactam I,马兜铃内酰胺I,Aristololactum |
Apoptosis; Caspase | Apoptosis; Proteases/Proteasome |
Aristolactam I (Aristololactum) 是马兜铃酸 I (AA-I) 的主要代谢产物,参与导致肾损伤的过程。它具有细胞毒性,通过诱导半胱天冬酶 3 依赖性途径中的细胞凋亡介导。 | |||
T2S2043 |
Dracorhodin perchlorate
Dracorhodin perochlorate,血竭素高氯酸盐,Dracohodin perochlorate |
Apoptosis; Others | Apoptosis; Others |
Dracorhodin perchlorate 是来源于中药血竭的一种天然产物。它抑制细胞生长,并以剂量和时间依赖性方式诱导成纤维细胞凋亡,将细胞周期阻滞在 G1 期,可作为抗乳腺癌的候选药物。 | |||
T72798 |
Ganodermaones B
|
Others | Others |
Ganodermaones B 是一种肾纤维化抑制剂,抑制 TGF-β1诱导的 collagen I 和 fibronectin 的表达。 | |||
TMA1743 |
Ergosterol peroxide
|
ERK; VEGFR; p38 MAPK; Wnt/beta-catenin; Akt; JAK; CDK; JNK; STAT; Antifection | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; JAK/STAT signaling; MAPK; Microbiology/Virology; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
Ergosterol peroxide is an inhibitor of osteoclast differentiation, which has antiviral, trypanocidal, antitumor, and antiangiogenic actions, it can stimulate Foxo3a activity by inhibiting pAKT and c-Myc and activating pro-apoptotic protein Puma and Bax to | |||
TN3753 |
Dalbergioidin
|
Tyrosinase; ROS; Akt; PI3K; TGF-beta/Smad | Cytoskeletal Signaling; Immunology/Inflammation; PI3K/Akt/mTOR signaling; Proteases/Proteasome; Stem Cells |
Dalbergioidin exhibits tyrosinase inhibitory activity with an IC50 of 20 mM. It shows a melanin biosynthesis inhibition zone in the culture plate of Streptomyces bikiniensis that has commonly been used as an indicator organism. Dalbergioidin protects MC3T3-E1 osteoblastic cells against H2O2-induced cell damage through activation of the PI3K/AKT/SMAD1 pathway, suggests that it may be useful in bone metabolism diseases, particularly osteoporosis. Dalbergioidin also ameliorates doxorubicin-induced ... |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-01128 |
LRG1 Protein, Mouse, Recombinant (His)
Leucine-rich α-2-glycoprotein,Leucine-rich alpha-2-glycoprot... |
Mouse | HEK293 Cells |
Diabetic nephropathy (DN) is an important public health concern of increasing proportions and the leading cause of end-stage renal disease (ESRD) in diabetic patients. It is one of the most common long-term microvascular complications of diabetes mellitus that is characterized by proteinuria and glomerular structural changes. LRG1 is a novel pro-angiogenic factors involved in the abnormal angiogenesis and renal fibrosis in DN. LRG1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammali... | |||
TMPK-00469 |
CXCL16 Protein, Human, Recombinant (hFc)
SR-PSOX,SCYB16,CXCL16,CXCLG16,SRPSOX |
Human | HEK293 Cells |
CXC chemokine ligand 16 (CXCL16) is a CXC soluble chemokine, an adhesion molecule and a cell surface scavenger receptor. CXCL16 regulates inflammation, tissue injury and fibrosis. Parenchymal renal cells, vascular wall cells, leukocytes and platelets express and/or release CXCL16 under the regulation of inflammatory mediators. CXCL16 expression is increased in experimental and human nephropathies. Targeting CXCL16 protected from experimental glomerular injury or interstitial fibrosis. CXCL16 Pro... | |||
TMPK-00138 |
CXCL16 Protein, Mouse, Recombinant (hFc)
SR-PSOX,SCYB16,SRPSOX,CXCLG16,CXCL16 |
Mouse | HEK293 Cells |
CXC chemokine ligand 16 (CXCL16) is a CXC soluble chemokine, an adhesion molecule and a cell surface scavenger receptor. CXCL16 regulates inflammation, tissue injury and fibrosis. Parenchymal renal cells, vascular wall cells, leukocytes and platelets express and/or release CXCL16 under the regulation of inflammatory mediators. CXCL16 expression is increased in experimental and human nephropathies. Targeting CXCL16 protected from experimental glomerular injury or interstitial fibrosis. CXCL16 Pro... | |||
TMPK-00526 |
LRG1 Protein, Cynomolgus, Recombinant (His)
Leucine-rich α-2-glycoprotein,LRG1,LRG,Leucine-rich alpha-2-... |
Cynomolgus | HEK293 Cells |
Diabetic nephropathy (DN) is an important public health concern of increasing proportions and the leading cause of end-stage renal disease (ESRD) in diabetic patients. It is one of the most common long-term microvascular complications of diabetes mellitus that is characterized by proteinuria and glomerular structural changes. LRG1 is a novel pro-angiogenic factors involved in the abnormal angiogenesis and renal fibrosis in DN. LRG1 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 ma... | |||
TMPK-00574 |
MRC2 Protein, Canine, Recombinant (His)
Mannose receptor C type 2 |
Canine | HEK293 Cells |
MRC2 (Mannose Receptor C Type 2) is a constitutively recycling endocytic receptor belonging to the mannose receptor family, which has been found to be closely involved with cancer metastasis. MRC2 expresses an extracellular fibronectin type II domain that binds to and internalizes collagen, suggesting that it may play a role in modulating renal fibrosis. MRC2 Protein, Canine, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 57.76 kDa and ... | |||
TMPK-01225 |
MRC2 Protein, Human, Recombinant (His)
C-type lectin domain family 13 member E, Endocytic receptor ... |
Human | HEK293 Cells |
MRC2 (Mannose Receptor C Type 2) is a constitutively recycling endocytic receptor belonging to the mannose receptor family, which has been found to be closely involved with cancer metastasis. MRC2 expresses an extracellular fibronectin type II domain that binds to and internalizes collagen, suggesting that it may play a role in modulating renal fibrosis. MRC2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 57.64 kDa and t... | |||
TMPY-01826 |
Relaxin 1/RLN1 Protein, Human, Recombinant (His)
RLXH1,H1RLX,relaxin 1,bA12D24.3.1,H1,RLN1,bA12D24.3.2 |
Human | HEK293 Cells |
Relaxin-1, also known as Prorelaxin H1 and RLN1, is a secreted protein that belongs to the insulin family. It is a peptide hormone that was first described in 1926 by Frederick Hisaw. Since its discovery as a reproductive hormone 8 years ago, relaxin has been implicated in a number of pregnancy-related functions involving extracellular matrix (ECM) turnover and collagen degradation. It is now becoming evident that relaxin's ability to reduce matrix synthesis and increase ECM degradation has impo... | |||
TMPJ-00332 |
tPA Protein, Human, Recombinant (His)
TPA,T-PA,t-plasminogen activator,Tissue plasminogen activato... |
Human | HEK293 Cells |
Tissue-type plasminogen activator (PLAT) is a protein that secreted into extracellular space. PLAT contains five domains: EGF-like domain, fibronectin type-I domain, 2 kringle domains and peptidase S1 domain. It belongs to the peptidase S1 family. The main function of this protein is to convert plasminogen into biologically active plasmin. As a protease, PLAT plays a crucial role in regulating blood fibrinolysis, maintaining the homeostasis of extracellular matrix and in modulating the post-tra... |